Showing 1 - 9 of 9
Case for SET reform
Oped, Postbag, Published on 08/12/2025
» Re: "Thai bourse seeks to jump start growth", (Business, Dec 6).
People want change
Oped, Postbag, Published on 09/09/2025
» Re: "Most Thais want parliament dissolved immediately, charter change: poll", (BP, Sept 7).
Unite to solve neglected diseases
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
The world's babies need antibiotics
Oped, Glenda Gray, Published on 28/11/2024
» Over the last half-century, the number of children who die before reaching the age of five has fallen dramatically, from around 20 million in 1960 to 4.9 million in 2022, largely owing to the Expanded Programme on Immunisation (EPI). Established by the World Health Organization (WHO) in 1974, the EPI has been extraordinarily successful in providing the youngest people with access to vaccines, saving more than 150 million lives. But while such progress is worthy of celebration, there is still much work to do, because newborns comprise half of all deaths in children under five each year, many of which are caused by infection.
More testing, treatment needed
Oped, Poonam Khetrapal, Published on 03/08/2023
» To mark World Hepatitis Day, the World Health Organization (WHO) is urging policymakers, health care providers and political and civil society leaders in the Southeast Asia region and globally to accelerate hepatitis testing and treatment, recognising that everyone, everywhere has just "one life" and "one liver" -- the theme of this year's event.
Don't forget about viral hepatitis
Oped, Poonam Khetrapal, Published on 29/07/2021
» The World Health Organization (WHO) Southeast Asia region is intensifying action to eliminate viral hepatitis as a public health threat by 2030. Globally, an estimated 296 million people live with chronic hepatitis B and around 58 million live with chronic hepatitis C. In 2019, viral hepatitis caused nearly 1.1 million deaths globally, despite the existence of safe and effective vaccines that can prevent hepatitis B and antiviral drugs that can manage chronic hepatitis B and cure most cases of hepatitis C. An estimated 60 million people in the region live with chronic hepatitis B and around 10.5 million live with chronic hepatitis C. In 2019, around 180,000 people in the region died of hepatitis B and about 38,000 died of hepatitis C -- both completely manageable.
A crucial social good: the case for jab passports
Oped, Peter Baldwin, Published on 20/05/2021
» Vaccine passports, and the questions of whether governments or businesses can require people to show them, have inspired controversy around the world.
Hope, solidarity amid coup crisis
Oped, Francesca Quinto, Published on 24/03/2021
» The sweet fragrance of jasmine flowers strung across the rear view mirror of a taxi I was in offered the only sense of familiarity in a country that had changed dramatically overnight. That morning, Feb 1, I had woken up stunned, like millions in Myanmar, to the news that the military had declared a state of emergency and seized power from the country's civilian leadership.
Ashes of democracy
Oped, Postbag, Published on 06/02/2021
» Re: "Myanmar coup sparks Asean concern", (Opinion, Feb 5).